Shenzhen Chipscreen Biosciences Co (688321) — Free Cash Flow Generation Index

Latest as of September 2025: -26.48x

Shenzhen Chipscreen Biosciences Co (688321) has a Free Cash Flow Generation Index of -26.48x as of September 2025. Free cash flow of CN¥-59.48 Million represents -26% of operating cash flow (CN¥2.25 Million). Explore 688321 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-26.48x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥-59.48 Million
CNY

Operating Cash Flow

CN¥2.25 Million
CNY

Capital Expenditures

CN¥61.73 Million
CNY

Shenzhen Chipscreen Biosciences Co Free Cash Flow Generation Index (2016–2024)

Historical FCF Generation Index trend for Shenzhen Chipscreen Biosciences Co across 7 annual periods. For the full cash flow conversion analysis, see Shenzhen Chipscreen Biosciences Co operating cash flow efficiency.

Annual Free Cash Flow Generation for Shenzhen Chipscreen Biosciences Co (2016–2024)

Year-by-year Free Cash Flow Generation Index for Shenzhen Chipscreen Biosciences Co. Check Shenzhen Chipscreen Biosciences Co investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 -2.53x CN¥-192.36 Million CN¥76.13 Million CN¥268.49 Million ▲ +69.3%
2022 -8.24x CN¥-356.87 Million CN¥43.30 Million CN¥400.17 Million ▼ -528.4%
2021 -1.31x CN¥-163.68 Million CN¥124.78 Million CN¥288.46 Million ▲ +49.4%
2020 -2.59x CN¥-242.65 Million CN¥93.62 Million CN¥336.27 Million ▲ +49.9%
2018 -5.18x CN¥-117.96 Million CN¥22.78 Million CN¥140.74 Million ▲ +89.1%
2017 -47.65x CN¥-130.09 Million CN¥2.73 Million CN¥132.82 Million ▼ -47043.9%
2016 -0.10x CN¥-6.04 Million CN¥59.77 Million CN¥65.81 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).